Sunscreens May Not Protect Against Melanoma Skin Cancer

February 17, 1998

New York, February 17, 1998 -- Sunscreens may not protect users from developing the deadly skin cancer, melanoma -- one of the fastest rising cancers in the United States, reports Dr. Marianne Berwick, an epidemiologist at Memorial Sloan-Kettering Cancer Center.

"After examining the available epidemiological data and conducting our own large case- control population-based study, we have found no relationship between sunscreen use at any age and the development of melanoma skin cancer," said Dr. Berwick at the Annual Meeting of the American Association for the Advancement of Science (AAAS) in Philadelphia, Pennsylvania.

The logic behind using sunscreen stems from many studies in scientific journals and articles in the lay press that have linked a specific number of sunburns to an increased risk for developing melanoma skin cancer. But when Dr. Berwick re-examined these results in a large population-based study, she found that people's reports of their sunburn histories were unreliable.

"When asked the same question at different times, people often gave inconsistent answers about their sunburn history," said Dr. Berwick.

Examining the relationship between sunscreen use and the development of skin cancer is further complicated by evidence that people who are sensitive to the sun engage in fewer activities in the bright sun and wear sunscreen when they do. But Dr. Berwick reports that evidence suggests that when these people develop melanoma, it is because they are genetically susceptible and likely to develop skin cancer regardless of the amount of sunlight exposure or protection from sunscreen. Also, it is likely that those people who are normally sun sensitive may use sunscreens to stay out in the sun longer -- thereby eliminating sunburn, which would have otherwise signaled them to get out of the sun. Subsequently, these people expose themselves to more sun than they should.

"Based on the evidence, we conclude that sunburn itself probably does not cause melanoma, but that it is an important sign of excessive sun exposure particularly among those who are genetically susceptible because of their skin-type," said Dr. Berwick.

More powerful determinants for the risk of melanoma appear to be genetically determined characteristics such as the number of moles a person has and their pigmentary phenotype, or the combination of skin, eye, and hair color. In data gathered from Dr. Berwick's large population-based study, the risk for melanoma was estimated by looking at these genetic characteristics, sun exposure in early life, as well as sun exposure 10 years prior to the development of melanoma. Dr. Berwick found that the melanoma risk for people with numerous moles was six times higher than that of someone with only a few moles. The risk for melanoma with the most sensitive pigmentary phenotype (those with red or blond hair and lighter colored eyes) was almost six times that of someone with the least sensitive phenotype.

Increased amounts of sun exposure have also been linked to the alarming rise in melanoma incidence -- the highest rising cancer in men and the second highest in women, after lung cancer. But Dr. Berwick reports that epidemiologic studies show that to the contrary, people are spending less constant time outdoors and thus engaging in more intermittent sun exposure, which may explain the increase in melanoma rates.

"The evidence indicates that chronic sun exposure may be protective for the development of melanoma because the skin has adapted to the sun, having become thicker as it has tanned. On the other hand, intermittent sun exposure appears to increase risk, making it much less protective," added Dr. Berwick.

Given the data, blanket advice to the public to wear sunscreens as protection against melanoma skin cancer at any time outdoors is not warranted.

"People need to focus on their individual risk characteristics, such as their pigmentary phenotype, their family history, and the type and number of moles they have. I recommend that people avoid the sun when they are clearly at high risk and that they should enjoy a reasonable amount of outdoor activities with less anxiety when they are clearly at reduced risk," advised Dr. Berwick.

Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Throughout its long, distinguished history, the Center has played a leadership role in defining the standard of care for patients with cancer. In 1997, Memorial Sloan-Kettering was named the nation's best cancer center for the fifth consecutive year by U.S. News and World Report.
-end-


Memorial Sloan Kettering Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.